You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 11, 2024

Details for Patent: 9,592,195


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,592,195 protect, and when does it expire?

Patent 9,592,195 protects BINOSTO and is included in one NDA.

This patent has twenty patent family members in sixteen countries.

Summary for Patent: 9,592,195
Title:Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
Abstract: A stable effervescent tablet, granule or powder composition free from excipients that may react with an effervescing organic acid component, comprising, an effective amount of a bisphosphonate bone resorption inhibitor, an effervescing organic acid component, an effervescing base component; wherein said composition is free of polyol binders and tableting lubricants; has a loss on drying of 0.25% (m/m) or less; has a complete disintegration time of no more than 180 seconds when placed in 3 to 8 fluid ounces of water at between 5-20.degree. C.; and said bisphosphonate is incorporated as a micronized particle or by spray drying and is completely solubdised in water within 2 minutes without stirring.
Inventor(s): Hayward; Marshall A. (Bridgewater, NJ), Schmidt; Timo (Schindellegi, CH)
Assignee: EffRx Pharmaceuticals SA (CH)
Application Number:13/991,523
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 9,592,195

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Radius BINOSTO alendronate sodium TABLET, EFFERVESCENT;ORAL 202344-001 Mar 12, 2012 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,592,195

PCT Information
PCT FiledDecember 05, 2011PCT Application Number:PCT/US2011/063341
PCT Publication Date:June 14, 2012PCT Publication Number: WO2012/078528

International Family Members for US Patent 9,592,195

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011338674 ⤷  Try a Trial
Brazil 112013010476 ⤷  Try a Trial
Canada 2820019 ⤷  Try a Trial
China 103140220 ⤷  Try a Trial
Denmark 2648702 ⤷  Try a Trial
European Patent Office 2648702 ⤷  Try a Trial
Spain 2716525 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.